Integrin αDβ2, an adhesion receptor up-regulated on macrophage foam cells, exhibits multiligand-binding properties

Blood

Volumn 107, Issue 4, 2006, Pages 1643-1650

  Yakubenko, Valentin P ^a   Yadav, Satya P ^a   Ugarova, Tatiana P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CHIMERIC PROTEIN; INTEGRIN; INTEGRIN ALPHA DEXTRO BETA2; SCLEROPROTEIN; UNCLASSIFIED DRUG; ALPHA INTEGRIN; CD11 ANTIGEN; ITGAD PROTEIN, HUMAN; LIGAND; PEPTIDE FRAGMENT;

ALPHA HELIX; ARTICLE; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; MACROPHAGE; PRIORITY JOURNAL; PROTEIN DOMAIN; UPREGULATION; WILD TYPE; AMINO ACID SEQUENCE; BINDING SITE; CHEMISTRY; FOAM CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANTIGENS, CD11; BINDING SITES; FOAM CELLS; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN ALPHA CHAINS; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

EID: 32644449297     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-06-2509     Document Type: Article

References (42)

1. 2, binds preferentially to ICAM-3. Immunity. 1995;3:683-690.
2. Noti JD. Expression of the myeloid-specific leukocyte integrin gene CD11d during macrophage foam cell differentiation and exposure to lipoproteins. Int J Mol Med. 2002;10:721-727.
3. Todd RF3, Arnaout MA, Rosin RE, Crowley CA, Peters WA, Babior BM. Subcellular localization of the large subunit of Mo1 (mo1 alpha; formerly gp110), a surface glycoprotein associated with neutrophil adhesion. J Clin Invest. 1984;74:1280-1290.
4. Borregaard N, Miller LJ, Springer TA. Chemoattractant-regulated fusion of a novel, mobilizable intracellular compartment with the plasma membrane in human neutrophils. Science. 1987;237:1204-1206.
5. Gray JL, Shankar R. Down regulation of CD11b and CD18 expression in atherosclerotic lesion-derived macrophages. Am Surg. 1995;61:674-679.
6. Van der Vieren M, Crowe DT, Hoekstra D, et al. The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. J Immunol. 1999;163:1984-1990.
7. Grayson MH, Van der Vierren, V, Sterbinsky SA, et al. alphadbeta2 integrin is a ligand for vascular cell adhesion molecule-1. Int Arch Allergy Immunol. 1999;118:263-264.
8. Getz GS. Immune function in atherogenesis. J Lipid Res. 2005;46:1-10.
9. Humphries MJ. Integrin structure. Biochem Soc Trans. 2000;28:311-340.
10. 2 in ligand binding promiscuity. J Biol Chem. 2002;277:48635-48642.
11. Lee J-O, Rieu P, Arnaout MA, Liddington R. Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18). Cell. 1995;80:631-638.
12. Anderson DC. The role of β2 integrins and intercellular adhesion molecule type 1 in inflammation. In: Granger DN and Schid-Schlobein GW, eds. Physiology and Pathophysiology of Leukocyte Adhesion. New York, NY: Oxford University Press; 1995:3-42.
13. McGuire SL, Bajt ML. Distinct ligand binding sites in the I domain of integrin αMβ2 that differentially affect a divalent cation-dependent conformation. J Biol Chem. 1995;270:25866-25871.
14. 2. J Biol Chem. 2001;275:13995-14003.
15. Vuento M, Vahery A. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J. 1979;183:331-337.
16. Yatohgo T, Izumi M, Kashiwagi H, Hayashi M. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct. 1988;13:281-292.
17. Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970;170:1095-1096.
18. 2 within the gamma-chain of fibrinogen. J Biol Chem. 1998;273:22519-22527.
19. 2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond. Proc Natl Acad Sci U S A. 2001;98:2387-2392.
20. 1-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. Exp Cell Res. 2000;260:73-84.
21. 1 during cell migration to fibronectin. Exp Cell Res. 2003;283:116-126.
22. Hilfiker A, Hilfiker-Kleiner D, Fuchs M, et al. Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II. Circulation. 2002;106:254-260.
23. Fan Z, Larson PJ, Bognacki J, et al. Tissue factor regulates plasminogen binding and activation. Blood. 1998;91:1987-1998.
24. Flick MJ, Du X, Witte DP, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest. 2004;113:1596-1606.
25. 2 in the γC-domain of fibrinogen. Biochemistry. 2003;42:9365-9373.
26. 2 as an adhesion receptor on peripheral blood monocytes for Cyr61 and connective tissue growth factor, immediate-early gene products expressed in atherosclerotic lesions. Blood. 2002;99:4457-4465.
27. 1(VLA-5). Blood. 2004;104:719-726.
28. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem. 1988;57:375-413.
29. Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 1990;60:577-584.
30. Schwartz BR, Wayner EA, Carlos TM, Ochs HD, Harlan JM. Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium. J Clin Invest. 1990;85:2019-2022.
31. Leu SJ, Lam SC, Lau LF. Pro-angiogenic activities of Cyr61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem. 2002;277:46248-46255.
32. 2. Blood. 2001;98:2448-2455.
33. 2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions. J Biol Chem. 2003;278:25808-25815.
34. 2-mediated cell migration to fibrinogen and its recognition peptides. J Exp Med. 2001;193:1123-1133.
35. Xiong J-P, Li R, Essafi M, Stehle T, Arnaout MA. An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem. 2000;275:38762-38767.
36. Campanero MR, Del Pozo MA, Arroyo AG, et al. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J Cell Biol. 1993;123:1007-1016.
37. Vorus-Jensen T, Ostermeier C, Shimaoka M, Hommel U, Springer TA. Structure and allosteric regulation of the αXβ2 integrin I domain. Proc Natl Acad Sci U S A. 2003;100:1873-1878.
38. Ma Q, Shimaoka M, Lu C, Jing H, Carman CV, Springer TA. Activation-induced conformational changes in the I domain region of lymphocyte function-associated antigen 1. J Biol Chem. 2002;277:10638-10641.
39. Lee J-O, Bankston LA, Arnaout MA, Liddington RC. Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure. 1995;3:1333-1340.
40. 1 on endothelial cells. J Biol Chem. 1997;272:5360-5366.
41. Kishimoto TK, Baldwin ET, Anderson DC. Inflammation: Basic Principles and Clinical Correlates. Philadelphia, PA: Lippincott Williams and Wilkins; 1999.
42. Llorda J, Angeli V, Liu J, Trogan E, Fisher EA, Randoph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A. 2004;101:11779-11784.